Evaluation of Continuous Non Invasive Blood Pressure With Adult Volunteers
Clinical Evaluation of Continuous Non-Invasive Blood Pressure Monitors With Adult Volunteers
1 other identifier
interventional
12
0 countries
N/A
Brief Summary
A study to collect data recorded by devices for cNIBP evaluation purposes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2021
CompletedFirst Posted
Study publicly available on registry
May 6, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedMay 6, 2021
April 1, 2021
2 months
April 20, 2021
April 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Data collection of NIBP measurement
To collect data recorded by devices for cNIBP evaluation purposes.
through study completion, average of one day
Secondary Outcomes (1)
Collect number of adverse events (AEs), serious adverse events (SAEs), and device issues
through study completion, an average of one day
Study Arms (1)
Ambulatory monitoring solution
EXPERIMENTALthis study has only one arm
Interventions
To measure blood pressure in different circumstances with noninvasive blood pressure device
Eligibility Criteria
You may qualify if:
- Healthy male or female, aged 18 years or older (≥18 years);
- Willing and able to give informed consent for participation in the study;
- Able and willing to comply with all the study requirements.
You may not qualify if:
- Who is pregnant or lactating;
- Who is a smoker;
- Who has consumed alcohol in the last 24 hours;
- Who has been previously diagnosed with Ataxia or balance disorder;
- Who has been previously diagnosed with Raynaud's disease/ syndrome/ phenomenon;
- Who has been previously a diagnosed cardiovascular condition requiring medication or has an internal pacemaker;
- Who has an injury, deformity, A-V fistula, or other characteristic limiting the placing of cuffs on arms/fingers;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GE Healthcarelead
Study Officials
- PRINCIPAL INVESTIGATOR
Juha Pärkkä
VTT
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2021
First Posted
May 6, 2021
Study Start
June 1, 2021
Primary Completion
July 31, 2021
Study Completion
September 1, 2021
Last Updated
May 6, 2021
Record last verified: 2021-04